PEPperPRINT produces and distributes peptide microarrays on demand using a proprietary platform technology based on a laser printing process. The company also provides the biotechnology and pharmaceutical industries with screening services built on more complex peptide libraries. Its peptide microarrays aim to enable individualised, fast and highly efficient investigation of proteins, enzymes and antibodies, opening new biomedical research opportunities. PEPperPRINT is a spin-off of the German Cancer Research Centre and is based in Heidelberg, Germany. The company received external funding to support commercialization. The funds will be used to commercialize the company’s product portfolio.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2010